In clinical practice, an atypical response to GDM treatment, e.g. no/little response to diet or metformin treatment, but strong response to insulin treatment indicates low insulin resistance, and is suggestive of insulin deficiency, thus justifying autoantibody testing. This evidence concerns the gene INS and gestational diabetes.